Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurodegenerative Diseases Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
HLundbeck A/S
Jiangsu Hansoh Pharmaceutical
Yumanity Therapeutics
Teva Pharmaceutical
Alector
Merck Serono
Pfizer
AstraZeneca
Novartis
Yangtze River Pharmaceutical Group
Chongqing Zein Pharmaceutical
UCB
Amarin
Eisai
Bayer Schering Pharma AG
Biogen Idec
Boehringer Ingelheim
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurodegenerative Diseases Drug Market Overview 2018-2029
-
1.1 China Neurodegenerative Diseases Drug Industry Development Overview
-
1.2 China Neurodegenerative Diseases Drug Industry Development History
-
1.3 China Neurodegenerative Diseases Drug Industry Market Size (2018-2029)
-
1.4 China Neurodegenerative Diseases Drug Market Analysis by Type from Production Side
-
1.4.1 China Neurodegenerative Diseases Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Neurodegenerative Diseases Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Neurodegenerative Diseases Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Neurodegenerative Diseases Drug Market Analysis by Application from Consumption End
-
1.5.1 China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Neurodegenerative Diseases Drug Market Analysis by Region
-
1.6.1 North China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurodegenerative Diseases Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurodegenerative Diseases Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurodegenerative Diseases Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Neurodegenerative Diseases Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurodegenerative Diseases Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurodegenerative Diseases Drug Industry Development
Chapter 3 Neurodegenerative Diseases DrugIndustry Chain Analysis
-
3.1 Neurodegenerative Diseases Drug Industry Chain
-
3.2 Neurodegenerative Diseases Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurodegenerative Diseases Drug Market
-
3.3 Neurodegenerative Diseases Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurodegenerative Diseases Drug Market
Chapter 4 China Neurodegenerative Diseases Drug Market, by Type
-
4.1 China Neurodegenerative Diseases Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurodegenerative Diseases Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurodegenerative Diseases Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Neurodegenerative Diseases Drug Production Volume and Growth Rate of Type 1
-
4.5.2 China Neurodegenerative Diseases Drug Production Volume and Growth Rate of Type 2
-
4.5.3 China Neurodegenerative Diseases Drug Production Volume and Growth Rate of Type 3
Chapter 5 China Neurodegenerative Diseases Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurodegenerative Diseases Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurodegenerative Diseases Drug Market Size and Growth Rate, by Application
-
5.5.1 China Neurodegenerative Diseases Drug Market Size and Growth Rate of Application 1
-
5.5.2 China Neurodegenerative Diseases Drug Market Size and Growth Rate of Application 2
-
5.5.3 China Neurodegenerative Diseases Drug Market Size and Growth Rate of Application 3
Chapter 6 China Neurodegenerative Diseases Drug Market, by Region
-
6.1 China Neurodegenerative Diseases Drug Production Volume and Production Value, by Region
-
6.2 China Neurodegenerative Diseases Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Neurodegenerative Diseases Drug Market Analysis
-
7.1 North China Neurodegenerative Diseases Drug Market, by Type
-
7.2 North China Neurodegenerative Diseases Drug Market, by Application
Chapter 8 Central China Neurodegenerative Diseases Drug Market Analysis
-
8.1 Central China Neurodegenerative Diseases Drug Market, by Type
-
8.2 Central China Neurodegenerative Diseases Drug Market, by Application
Chapter 9 South China Neurodegenerative Diseases Drug Market Analysis
-
9.1 South China Neurodegenerative Diseases Drug Market, by Type
-
9.2 South China Neurodegenerative Diseases Drug Market, by Application
Chapter 10 East China Neurodegenerative Diseases Drug Market Analysis
-
10.1 East China Neurodegenerative Diseases Drug Market, by Type
-
10.2 East China Neurodegenerative Diseases Drug Market, by Application
Chapter 11 Northeast China Neurodegenerative Diseases Drug Market Analysis
-
11.1 Northeast China Neurodegenerative Diseases Drug Market, by Type
-
11.2 Northeast China Neurodegenerative Diseases Drug Market, by Application
Chapter 12 Southwest China Neurodegenerative Diseases Drug Market Analysis
-
12.1 Southwest China Neurodegenerative Diseases Drug Market, by Type
-
12.2 Southwest China Neurodegenerative Diseases Drug Market, by Application
Chapter 13 Northwest China Neurodegenerative Diseases Drug Market Analysis
-
13.1 Northwest China Neurodegenerative Diseases Drug Market, by Type
-
13.2 Northwest China Neurodegenerative Diseases Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 HLundbeck A/S
-
14.1.1 HLundbeck A/S Company Profile
-
14.1.2 HLundbeck A/S Neurodegenerative Diseases Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Jiangsu Hansoh Pharmaceutical
-
14.2.1 Jiangsu Hansoh Pharmaceutical Company Profile
-
14.2.2 Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Yumanity Therapeutics
-
14.3.1 Yumanity Therapeutics Company Profile
-
14.3.2 Yumanity Therapeutics Neurodegenerative Diseases Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Teva Pharmaceutical
-
14.4.1 Teva Pharmaceutical Company Profile
-
14.4.2 Teva Pharmaceutical Neurodegenerative Diseases Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Alector
-
14.5.1 Alector Company Profile
-
14.5.2 Alector Neurodegenerative Diseases Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Merck Serono
-
14.6.1 Merck Serono Company Profile
-
14.6.2 Merck Serono Neurodegenerative Diseases Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pfizer
-
14.7.1 Pfizer Company Profile
-
14.7.2 Pfizer Neurodegenerative Diseases Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Profile
-
14.8.2 AstraZeneca Neurodegenerative Diseases Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novartis
-
14.9.1 Novartis Company Profile
-
14.9.2 Novartis Neurodegenerative Diseases Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Yangtze River Pharmaceutical Group
-
14.10.1 Yangtze River Pharmaceutical Group Company Profile
-
14.10.2 Yangtze River Pharmaceutical Group Neurodegenerative Diseases Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Chongqing Zein Pharmaceutical
-
14.11.1 Chongqing Zein Pharmaceutical Company Profile
-
14.11.2 Chongqing Zein Pharmaceutical Neurodegenerative Diseases Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 UCB
-
14.12.1 UCB Company Profile
-
14.12.2 UCB Neurodegenerative Diseases Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Amarin
-
14.13.1 Amarin Company Profile
-
14.13.2 Amarin Neurodegenerative Diseases Drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Eisai
-
14.14.1 Eisai Company Profile
-
14.14.2 Eisai Neurodegenerative Diseases Drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Bayer Schering Pharma AG
-
14.15.1 Bayer Schering Pharma AG Company Profile
-
14.15.2 Bayer Schering Pharma AG Neurodegenerative Diseases Drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Biogen Idec
-
14.16.1 Biogen Idec Company Profile
-
14.16.2 Biogen Idec Neurodegenerative Diseases Drug Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Boehringer Ingelheim
-
14.17.1 Boehringer Ingelheim Company Profile
-
14.17.2 Boehringer Ingelheim Neurodegenerative Diseases Drug Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurodegenerative Diseases Drug Industry Research Conclusions
-
15.2 Neurodegenerative Diseases Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurodegenerative Diseases Drug Industry Market Size (2018-2029)
-
Figure China Neurodegenerative Diseases Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Neurodegenerative Diseases Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Neurodegenerative Diseases Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurodegenerative Diseases Drug Market Size and Growth Rate from 2018-2029
-
Figure Neurodegenerative Diseases Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurodegenerative Diseases Drug Market Share by Type in 2018
-
Figure China Neurodegenerative Diseases Drug Market Share by Type in 2023
-
Figure China Neurodegenerative Diseases Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Market Share by Application in 2018
-
Figure China Neurodegenerative Diseases Drug Market Share by Application in 2023
-
Figure China Neurodegenerative Diseases Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Neurodegenerative Diseases Drug Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Neurodegenerative Diseases Drug Production Volume by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Production Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Production Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Production Value by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Production Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Production Value Share by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Sales Volume by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Sales Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Sales Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Sales Value by Region (2018-2023)
-
Table China Neurodegenerative Diseases Drug Sales Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Diseases Drug Sales Value Share by Region (2018-2023)
-
Table North China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table North China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure North China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table North China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table North China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table Central China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table Central China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table Central China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table South China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table South China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure South China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table South China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table South China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table East China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table East China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure East China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table East China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table East China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table Northeast China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table Southwest China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurodegenerative Diseases Drug Production Volume by Type (2018-2023)
-
Table Northwest China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurodegenerative Diseases Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurodegenerative Diseases Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurodegenerative Diseases Drug Sales Volume Share by Application (2018-2023)
-
Table HLundbeck A/S Company Profile
-
Table HLundbeck A/S Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Jiangsu Hansoh Pharmaceutical Company Profile
-
Table Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Yumanity Therapeutics Company Profile
-
Table Yumanity Therapeutics Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Company Profile
-
Table Teva Pharmaceutical Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Alector Company Profile
-
Table Alector Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Merck Serono Company Profile
-
Table Merck Serono Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Yangtze River Pharmaceutical Group Company Profile
-
Table Yangtze River Pharmaceutical Group Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Chongqing Zein Pharmaceutical Company Profile
-
Table Chongqing Zein Pharmaceutical Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table UCB Company Profile
-
Table UCB Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Amarin Company Profile
-
Table Amarin Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Eisai Company Profile
-
Table Eisai Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer Schering Pharma AG Company Profile
-
Table Bayer Schering Pharma AG Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Biogen Idec Company Profile
-
Table Biogen Idec Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Neurodegenerative Diseases Drug Revenue, Price and Gross (2018-2023)
-
